July 14, 2022
RFA-HL-23-015 - New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial
RFA-HL-23-016 - New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)
National Institute of Mental Health (NIMH)
The purpose of this Notice is to inform potential applicants of NIMH's participation, effective immediately, in RFA-HL-23-015, "New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3)" and RFA-HL-23-016, "New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24)" and outline NIMH's areas of interest.
The following text has been added to reflect NIMH's participation in this FOA:
Part 1. Overview Information
Components of Participating Organizations
National Institute of Mental Health (NIMH)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Minority Health and Health Disparities (NIMHD)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.242
Part 2. Section I. Funding Opportunity Description
NIMH Area of Interest: NIMH is interested in research that can quantify the prevalence and characterize the clinical trajectories and outcomes of mental health disorders in Asian American, Native Hawaiian, and Pacific Islander subpopulations. Areas of high interest include, but are not limited to:
For more information, review the NIMH Strategic Plan.
Per NOT-MH-20-067, NIMH expects that grant applications involving human research participants will collect a minimum set of Common Data Elements. For research involving adults, the expected data collection instruments include demographic measures (age, sex at birth), the Self-Rated Level 1 Cross-Cutting Symptom Measure-Adult (DSM-5-TR), a measure of impairment (WHODAS), and measures related to anxiety and depression (PHQ-9, GAD-7).
Part 2. Section II. Award Information
Funds Available and Anticipated Number of Awards:
NIMH intends to commit up to $500,000 per year for FY 2023-2029 to co-fund applications in response to RFA-HL-23-015 and RFA-HL-23-016.
Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Lauren Hill, Ph.D.
National Institutes of Mental Health (NIMH)
Telephone: 301-443-2638
Email: [email protected]
Financial/Grants Management Contact(s)
Tamara Kees
National Institute of Mental Health (NIMH)
Telephone: 301-443-8811
Email: [email protected]
Lauren Hill, Ph.D.
National Institutes of Mental Health (NIMH)
Telephone: 301-443-8811
Email: [email protected]